Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Classifica tra le azioni #47
Merck & Co., Inc. operates as a healthcare company worldwide. It operates... Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Prezzo delle azioni
$115.67
Capitalizzazione di mercato
$285.98B
Variazione (1 giorno)
1.30%
Variazione (1 anno)
25.31%
Paese
US
Scambia Merck & Co., Inc. (MRK)

Categoria

Utile per Merck & Co., Inc. (MRK)
Utile nel Dec 2025 TTM: $21.07B
Secondo gli ultimi rapporti finanziari di Merck & Co., Inc., gli utili attuali della società sono $21.07B. Nel 2024, la società ha registrato un utile di $19.94B, un aumento rispetto a agli utili del 2023, che erano di $1.89B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Merck & Co., Inc. dal 2000 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $21.07B 0.00%
2025 $21.07B 5.67%
2024 $19.94B 955.37%
2023 $1.89B -88.51%
2022 $16.44B 18.48%
2021 $13.88B 136.72%
2020 $5.86B -18.24%
2019 $7.17B -17.58%
2018 $8.70B 33.43%
2017 $6.52B 39.97%
2016 $4.66B -13.74%
2015 $5.40B -68.75%
2014 $17.28B 211.69%
2013 $5.55B -36.55%
2012 $8.74B 19.16%
2011 $7.33B 343.68%
2010 $1.65B -89.19%
2009 $15.29B 53.96%
2008 $9.93B 194.63%
2007 $3.37B -45.82%
2006 $6.22B -15.51%
2005 $7.36B -7.98%
2004 $8.00B -11.59%
2003 $9.05B -6.22%
2002 $9.65B -2.98%
2001 $9.95B 1.26%
2000 $9.82B 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
$25.73B 22.13%
US
$12.40B -41.13%
GB
$32.58B 54.65%
US
$6.60B -68.69%
US
$16.35B -22.38%
CH